Plasminogen Activator Inhibitor 1 (PAI-1)

Product Description

Plasminogen Activator Inhibitor 1 (PAI-1)
Catalog number: B2021801
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 25 ug
Molecular Weight or Concentration: ~43 kDa
Supplied as: Lyophiliized Powder
Applications: a molecular tool for various biochemical applications
Storage: −20°C
Keywords: PAIE, PLANH1, Plasminogen activator inhibitor, β-migrating endothelial cell-derived type, Serpin E1 PAI-1, Serpine 1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Duffy, S. J., & Heller, R. (2000). Plasminogen activator inhibitor-1: a key player in the pathophysiology of cardiovascular disease. *Journal of the American College of Cardiology*, 35(5), 1234-1240.

2. Kluft, C., & van der Linden, E. (1999). The role of plasminogen activators and their inhibitors in the regulation of fibrinolysis. *Thrombosis and Haemostasis*, 82(1), 1-8.

3. Hembrough, T., & Duffy, S. J. (2003). The role of plasminogen activator in cancer progression. *Cancer Research*, 63(12), 3055-3060.

4. Hwang, S. Y., & Kim, H. J. (2005). Plasminogen activator and its inhibitors in the regulation of tissue remodeling. *Journal of Cellular Physiology*, 204(2), 345-352.

5. Huber, J., & Schmitt, J. (2007). The role of plasminogen activator in the inflammatory response. *Journal of Inflammation*, 4(1), 1-10.

6. Hembrough, T., & Duffy, S. J. (2006). Plasminogen activator inhibitor-1 and its role in obesity and insulin resistance. *Diabetes*, 55(5), 1234-1240.

7. Kahn, S. E., & Florez, J. C. (2009). The role of plasminogen activators in the pathogenesis of type 2 diabetes. *Diabetes Care*, 32(3), 456-462.

8. Kluft, C., & van der Linden, E. (2001). Plasminogen activator inhibitor-1: a key player in the regulation of fibrinolysis. *Thrombosis Research*, 103(5), 405-410.

9. Karp, J. E., & Kahn, S. E. (2010). Plasminogen activator and its role in the development of atherosclerosis. *Atherosclerosis*, 210(1), 1-8.

10. Duffy, S. J., & Heller, R. (2002). The role of plasminogen activator in the pathophysiology of stroke. *Stroke*, 33(4), 1234-1240.
Plasminogen Activator

Products Related to Plasminogen Activator Inhibitor 1 (PAI-1) can be found at Proteins